Intense 68Ga-Pentixafor Activity in Aldosterone-Producing Adrenal Adenomas.
暂无分享,去创建一个
L. Huo | Yushi Zhang | A. Tong | Jin Wen | J. Ding
[1] A. Buck,et al. Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT , 2019, The Journal of Nuclear Medicine.
[2] A. Buck,et al. CXCR4-Directed Imaging in Solid Tumors , 2019, Front. Oncol..
[3] A. Buck,et al. Chemokine Receptor 4 Expression in Primary Sjögren's Syndrome. , 2018, Clinical nuclear medicine.
[4] Z. Özkan,et al. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT. , 2018, Clinical nuclear medicine.
[5] Jun Feng,et al. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia. , 2018, Clinical nuclear medicine.
[6] Q. Pan,et al. Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT. , 2018, Clinical nuclear medicine.
[7] A. Buck,et al. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma , 2018, Hypertension.
[8] T. Derlin,et al. Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque Using 68Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden , 2017, The Journal of Nuclear Medicine.
[9] W. Staab,et al. 68Ga-Pentixafor PET/CT Imaging of Chemokine Receptor CXCR4 in Chronic Infection of the Bone: First Insights , 2017, The Journal of Nuclear Medicine.
[10] J. Slotta-Huspenina,et al. Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities , 2017, EJNMMI Research.
[11] Michael Lassmann,et al. Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach , 2017, Theranostics.
[12] R. Kapoor,et al. 68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in non-small cell variant , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[13] Johannes Ettl,et al. First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers , 2016, The Journal of Nuclear Medicine.
[14] T. Derlin,et al. Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDG. , 2016, Clinical nuclear medicine.
[15] S. Nekolla,et al. Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI , 2016, Journal of Nuclear Cardiology.
[16] T. Derlin,et al. Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction. , 2015, JACC. Cardiovascular imaging.
[17] A. Buck,et al. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients , 2017, Clinical nuclear medicine.
[18] Saskia,et al. Targeting CXCR 4 ( CXC Chemokine Receptor Type 4 ) for Molecular Imaging of Aldosterone-Producing Adenoma , 2022 .